Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
385M
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
105M
-
Shares change
-
+26.5M
-
Total reported value, excl. options
-
$1.68B
-
Value change
-
+$425M
-
Put/Call ratio
-
0.39
-
Number of buys
-
84
-
Number of sells
-
-61
-
Price
-
$15.92
Significant Holders of Moderna, Inc. - COMMON STOCK (MRNA) as of Q3 2019
174 filings reported holding MRNA - Moderna, Inc. - COMMON STOCK as of Q3 2019.
Moderna, Inc. - COMMON STOCK (MRNA) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 105M shares
of 385M outstanding shares and own 27.38% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (17M shares), FMR LLC (12.4M shares), BlackRock Inc. (8.35M shares), Theleme Partners LLP (5.61M shares), Ropes Wealth Advisors LLC (4.99M shares), Bellevue Group AG (4.84M shares), VIKING GLOBAL INVESTORS LP (4.68M shares), Artal Group S.A. (4.61M shares), BANQUE PICTET & CIE SA (3.95M shares), and FIDUCIARY TRUST CO (3.66M shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.